Merrimack Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
155,303.00
124,129.00
185,707.00
21,626.00
93,543.00
71,862
Total Accounts Receivable
5,857.00
3,313.00
6,483.00
275.00
100.00
-
Inventories
-
-
3,717.00
-
-
-
Other Current Assets
5,484.00
4,654.00
5,487.00
35,534.00
1,403.00
4,240
Total Current Assets
166,644.00
132,096.00
201,394.00
57,435.00
95,046.00
76,102
Net Property, Plant & Equipment
13,364.00
14,502.00
21,915.00
14,212.00
6,467.00
2,269
Total Investments and Advances
584.00
584.00
584.00
674.00
11,225.00
7,428
Intangible Assets
11,650.00
11,330.00
10,960.00
-
-
-
Other Assets
175.00
144.00
27.00
9,162.00
4,588.00
2,744
Total Assets
192,417.00
158,656.00
234,880.00
81,483.00
117,326.00
88,543
ST Debt & Current Portion LT Debt
8,248.00
13,346.00
-
-
-
Accounts Payable
1,889.00
2,510.00
5,049.00
2,692.00
2,887.00
Income Tax Payable
-
467.00
445.00
1,402.00
1,402.00
Other Current Liabilities
47,597.00
94,819.00
98,252.00
84,128.00
15,488.00
Total Current Liabilities
57,734.00
111,142.00
103,746.00
88,222.00
19,777.00
Long-Term Debt
103,427.00
106,806.00
257,655.00
216,861.00
-
Deferred Taxes
507.00
496.00
1,045.00
-
-
Other Liabilities
73,877.00
42,283.00
56,123.00
29,059.00
1,265.00
Total Liabilities
235,545.00
260,727.00
418,569.00
334,142.00
21,042.00
Common Equity (Total)
43,465.00
102,140.00
183,928.00
251,120.00
96,284.00
Total Shareholders' Equity
43,465.00
102,140.00
183,928.00
251,120.00
96,284.00
Total Equity
43,128.00
102,071.00
183,689.00
252,659.00
96,284.00
Liabilities & Shareholders' Equity
192,417.00
158,656.00
234,880.00
81,483.00
117,326.00
Accumulated Minority Interest
337.00
69.00
239.00
1,539.00
-
About Merrimack Pharmaceuticals
View Profile
